Valuation: Cenra Inc.

Market Cap 5.17B 161M 141M 130M 120M 228M 15.28B 232M 1.56B 605M 7.54B 604M 591M 26.06B P/E 2024
15.1x
P/E 2025 14x
Enterprise Value 7.43B 231M 202M 186M 173M 328M 21.94B 333M 2.24B 869M 10.83B 868M 849M 37.43B EV / Sales 2024
0.9x
EV / Sales 2025 0.83x
Free-Float
61.28%
Yield 2024
2.72%
Yield 2025 2.99%
1 day-0.56%
1 week+0.57%
Current month+1.29%
1 month-0.56%
3 months+7.76%
6 months+6.95%
Current year+5.99%
1 week 34.45
Extreme 34.45
35.85
1 month 34.05
Extreme 34.05
36.2
Current year 31.55
Extreme 31.55
36.6
1 year 31.55
Extreme 31.55
36.6
3 years 29
Extreme 29
44.55
5 years 29
Extreme 29
44.55
10 years 29
Extreme 29
44.55
Manager TitleAgeSince
Chief Executive Officer - 2020-11-04
Director of Finance/CFO - 2014-03-06
Chief Administrative Officer - -
Director TitleAgeSince
Director/Board Member - 2016-05-26
Chairman - 2020-11-04
Director/Board Member - 2020-01-16
Change 5-day change 1-year change 3-year change Capi.($)
-0.56%+0.57%-2.61% - 162M
-0.49%+1.53%+13.55%+82.58% 48.11B
-1.61%+5.55%+70.04%+116.16% 37.88B
-1.39%-0.16%-4.06%+42.16% 12.47B
+0.44%+2.83%+15.18%+96.06% 12B
+0.38%+2.76%+34.19%+120.25% 9.03B
-0.16%+1.91%+22.31%+47.95% 7.24B
+0.20%+2.01%+55.16%-3.74% 7.09B
-2.81%+17.66%-18.38%+20.93% 6.54B
-0.26%+3.58%+23.74%+238.93% 6.72B
Average -0.58%+3.96%+20.91%+84.59% 14.72B
Weighted average by Cap. -0.71%+3.97%+29.45%+89.75%

Financials

2024 2025
Net sales 8.92B 278M 243M 224M 207M 394M 26.34B 400M 2.68B 1.04B 13B 1.04B 1.02B 44.93B 8.57B 267M 233M 215M 199M 378M 25.31B 385M 2.58B 1B 12.49B 1B 979M 43.17B
Net income 317M 9.87M 8.64M 7.96M 7.38M 14.01M 937M 14.24M 95.49M 37.14M 463M 37.07M 36.27M 1.6B 300M 9.34M 8.17M 7.53M 6.98M 13.25M 886M 13.46M 90.29M 35.11M 437M 35.05M 34.29M 1.51B
Net Debt 2.46B 76.46M 66.91M 61.66M 57.15M 108M 7.26B 110M 739M 288M 3.58B 287M 281M 12.38B 2.26B 70.22M 61.45M 56.63M 52.49M 99.64M 6.66B 101M 679M 264M 3.29B 264M 258M 11.37B
Logo Cenra Inc.
Cenra Inc is a Taiwan-based company mainly engaged in the provision of general investment related businesses. Through its subsidiary, the Company conducts the development, manufacturing and sales of pharmaceuticals, agricultural and livestock drugs, personal hygiene and health products, as well as the import and sale of medical instruments. Its subsidiaries’ products are pharmaceuticals and health products, including human medicines, such as prescription and indicated drugs, over-the-counter medicines, and disease treatment products; medical equipment, such as blood pressure monitors, blood glucose meters, and artificial joints; animal medicines, supplementary feeds, and feed additives, providing animal treatment, disease prevention, and nutritional supplement products; daily necessities, such as toothpaste, tooth powder, mouthwash and other oral hygiene and health products, hand cleansers, dry hand sanitizers, shower gels, medicated soaps and lotion products, and skin care series.
Employees
-
Date Price Change Volume
26-07-07 NT$35.40 -0.56% 232,739
26-07-06 NT$35.60 +1.71% 305,054
26-07-03 NT$35.00 +1.01% 375,423
26-07-02 NT$34.65 0.00% 152,883
26-07-01 NT$34.65 -0.86% 208,142
  1. Stock Market
  2. Stocks
  3. 3716 Stock